Financial comparisons Formycon AG

Equities

Market Closed - Xetra Other stock markets 16:35:43 06/02/2026 GMT			After hours 18:44:16
23.00 ^EUR	+0.88%		23.12	+0.54%

12-23	Formycon Obtains US FDA Approval for Interchangeable Lucentis Biosimilar	MT
12-23	Formycon AG - FDA approves biologics license application (BLA) for additional ranibizumab biosimilar under trade name Nufymco	RE

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
FORMYCON AG	72.13M	-180.37%	-33.79%	-26.06%	-	2.27x
LONZA GROUP AG	7.25B	9.67%	17.9%	6.77%	3.48%	1.5x
BEONE MEDICINES AG	3.81B	-16.92%	-14.91%	-18.77%	-11%	4.06x
IQVIA HOLDINGS INC.	15.4B	8.91%	20.12%	33.53%	5.12%	3.33x
CELLTRION, INC.	2.41B	11.88%	13.83%	2.46%	2.14%	1.28x
MEDPACE HOLDINGS, INC.	2.11B	19.17%	21.38%	58.42%	21.52%	-1.39x
EUROFINS SCIENTIFIC SE	7.2B	5.84%	14.63%	7.8%	3.73%	1.93x
IONIS PHARMACEUTICALS, INC.	705M	-64.4%	-67.38%	-93.12%	-15.15%	2.26x
ASCENDIS PHARMA A/S	376M	-103.97%	-76.66%	-	-37.71%	-1.14x
ICON PUBLIC LIMITED COMPANY	8.28B	9.56%	19.29%	12.39%	6.87%	1.66x
BIO-TECHNE CORPORATION	1.22B	6.02%	31.45%	15.37%	11.65%	0.43x
QIAGEN N.V.	1.98B	4.23%	28.66%	13.31%	8.32%	0.34x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	4.05B	0.25%	19.9%	15.1%	6.78%	2.05x
TEMPUS AI, INC.	693M	-107.63%	-20.47%	-	-25.37%	0.13x
ABIVAX	12.94M	-1,409.6%	-1,383.2%	-148.95%	-	0.4x
PRAXIS PRECISION MEDICINES, INC.	8.55M	-2,137.48%	-2,340.29%	-70.98%	-64.03%	1.96x
BLUEPRINT MEDICINES CORPORATION	509M	-13.19%	-41.67%	-31.26%	-21.6%	-0.14x
HANGZHOU TIGERMED CONSULTING CO., LTD	905M	6.14%	7.92%	1.94%	1.39%	0.27x
Average	3.17B	-219.55%	-210.18%	-13.88%	-6.49%	1.18x
Weighted average by Cap.	4.73B	-113.74%	-109.14%	-4.31%	-3.45%	1.59x